P

Paratek Pharmaceuticals Inc
F:N4CN

Watchlist Manager
Paratek Pharmaceuticals Inc
F:N4CN
Watchlist
Price: 2.024 EUR Market Closed
Market Cap: 115.9m EUR

Wall Street
Price Targets

N4CN Price Targets Summary
Paratek Pharmaceuticals Inc

There are no price targets for N4CN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Paratek Pharmaceuticals Inc Competitors:
Price Targets
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
11% Upside
JNJ
Johnson & Johnson
3% Upside
MDWD
Mediwound Ltd
71% Upside
4746
Formosa Laboratories Inc
76% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
21% Upside
195940
HK Inno.N Corp
25% Upside
033270
Korea United Pharm Inc
48% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
113% Upside

Revenue
Forecast

Revenue Estimate
Paratek Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Paratek Pharmaceuticals Inc's revenue is 57%.

57%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Paratek Pharmaceuticals Inc

Operating Income forecast
is not available for
Paratek Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Paratek Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is N4CN's stock price target?
Not Available

N4CN doesn't have any price targets made by Wall Street professionals.

Back to Top